Breathe Well Live Well
|
Phase II Data On Reslizumab Suggest Compound Improves Asthma Control And Lung …
Biomed Middle East Phase II data presented on a new investigational compound called reslizumab suggest a trend toward improvement in asthma control associated with a … |
View full post on asthma – Google News
|
Phase II Data On Reslizumab Suggest Compound Improves Asthma Control And Lung …
Medical News Today (press release) Phase II data presented on a new investigational compound called reslizumab suggest a trend toward improvement in asthma control associated with a … |
View full post on asthma – Google News
Condition: Asthma
Interventions: Drug: 1440115; Drug: Placebo
Sponsor: Octagon Research Solutions, Inc.
Not yet recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
An experimental compound appears to improve metabolic abnormalities associated with obesity, according to a preliminary study led by researchers at the National Institutes of Health, A report of the study, which was conducted with obese mice, appears online today in the Journal of Clinical Investigation.
View full post on National Institutes of Health (NIH) News Releases